Prostate cancer — all decisions

The Board granted service connection for prostate cancer, which is presumed to be related to the Veteran's exposure to herbicide agents during his service in Vietnam.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there was no credible evidence of in-service exposure to herbicides and no direct link between the Veteran's active duty service and his diagnosis.

The Board granted service connection for prostate cancer under the PACT Act, presumptively linking it to toxic exposure during the Gulf War.

The Board remands the issue of entitlement to an increased evaluation for prostate cancer residuals, greater than 30 percent from August 1, 2013, to December 22, 2022, due to a need for clarification regarding the Veteran's PSA findings and the determination of biochemical recurrence.

The Board granted an effective date of July 29, 2022, for the award of service connection for prostate cancer.

The appeal for service connection for heart disease and prostate cancer was dismissed due to the Veteran's death during the pendency of the appeal.

The Board denied service connection for hypertension, atrial fibrillation, diabetes mellitus, type II, premature atrial contraction, and prostate cancer as there was no evidence of in-service injury or disease related to these conditions.

The Board remands the claims for service connection and increased ratings to obtain additional evidence, including outstanding VA treatment records.

The Board remands the claims for service connection for prostate cancer and an eye disorder to obtain adequate medical opinions on direct and secondary theories of entitlement.

The Board granted a 40 percent disability rating for the service-connected residuals of prostate cancer with urinary frequency, effective February 1, 2022.

The Board denied service connection for diabetes mellitus type II, chronic kidney disease, prostate cancer, and prostate gland (injuries infections hypertrophy) as the evidence did not support a finding that these conditions were incurred in or aggravated by active service. The claim for hypertension was remanded for further development.

The Board granted service connection for prostate cancer under the PACT Act and denied it on other bases, while granting service connection for a cardiovascular disorder.

The appeal for increased ratings for bilateral hearing loss and prostate cancer residuals was denied, while the service connection claim for an acquired psychiatric disability was remanded. The proposed reduction of the disability rating for surgical scars is dismissed.

The Board granted service connection for prostate cancer due to exposure to contaminated water at Camp Lejeune.

The Board granted service connection for non-Hodgkin's lymphoma and an earlier effective date of March 17, 2017, for the award of Dependents Educational Assistance (DEA) based on permanent and total disability status.

The Board denied the veteran's appeal for an earlier effective date than October 26, 2021, for the 100 percent evaluation of service-connected prostate cancer.

The Board remands the claims for service connection for hypertension and prostate cancer to obtain outstanding private treatment records and additional medical opinions.

The Board granted service connection for heart condition, hypertension, prostate cancer, and skin cancer due to in-service herbicide exposure but denied service connection for bilateral hearing loss, tinnitus, and obstructive sleep apnea.

The Board denied service connection for heart disease, DMII, prostate cancer, RLE and LLE peripheral neuropathy, and erectile dysfunction as they are not shown to be causally or etiologically related to any disease, injury, or incident during service.

The Veteran's claim for service connection for tinnitus was granted, while claims for initial compensable disability ratings for prostate cancer and erectile dysfunction were denied. The appeal also included a request for special monthly compensation (SMC) based on loss of use of a creative organ, which was denied.